1/2

Export Ready

Ponatinib Tablets Ponaxen 15mg

Name: Ponatinib Tablets Ponaxen 15mg
SKU: 8495605
Price: 187.04 USD
Availability: InStock

Sold by Armour Nutrition · Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Price

₹ 187.04 /Bottle

In stock

Inclusive of all taxes

Minimum order: 1 Bottle

Export Snapshot

MOQ

1 Bottle

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for Armour Nutrition.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Bengaluru Dispatch on request Verified seller

Armour Nutrition

Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

Not shared

Employees

–

GST

29AQTPJ8785C1Z2

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2019

Turnover

Incorporation Type

On request

Verified Seller IMPORT EXPORT LICENSE ISSUED BY GOVERMENT OF INDIA GST ISSUED BY GOVERNMENT DRUG LICENSE ISSUED BY HEALTH AUTHORITY GOVERMENT

Product details

What are the specifications of this product?

Overview

Ponatinib Tablets Ponaxen 15mg are prescribed for treating specific leukemias, such as CML and ALL. As a tyrosine kinase inhibitor, Ponatinib targets proteins that aid cancer cell growth. Patients must follow their doctor's dosage instructions and monitor for side effects. Manufactured with high-quality standards, Ponaxen offers an effective approach to leukemia treatment.

Product Description

Ponatinib Tablets Ponaxen 15mg contain Ponatinib, a tyrosine kinase inhibitor used in the treatment of certain types of leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Ponatinib works by blocking specific proteins that promote the growth of cancer cells. Each bottle contains a specific number of tablets, with dosages determined by a healthcare provider based on individual patient needs. Patients should adhere to prescribed dosages and report any side effects to their doctor immediately. Ponaxen is manufactured under stringent quality standards to ensure its efficacy and safety.

Description provided by Armour Nutrition.

Specifications

Tablet Strength	15mg Ponatinib
Tablet Type	Film-coated oral tablet
Pharmacological Category	Antineoplastic Agent
CAS Number	943319-70-8
Shelf Life	Typically 24 months from manufacturing date
Storage Conditions	Store at 20°C to 25°C, protect from moisture and light
Manufacturer	Ponaxen Pharmaceuticals
Regulatory Approval	Approved for use under applicable regional medical safety authorities
Packaging Details	Bottles containing a specific number of 15mg tablets per order
Prescription Requirement	Prescription mandatory

Use cases

Category	Pharmaceuticals > Oncology > Antineoplastic Agents > Tyrosine Kinase Inhibitors
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Bottle
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ponatinib Tablets Ponaxen 15mg. Answers compiled from verified sellers' commercial terms and platform data.

Q: What specific leukemias are treated with Ponatinib Tablets Ponaxen 15mg?

A: Ponatinib Tablets Ponaxen 15mg are specifically indicated for treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Q: How does Ponatinib in Ponaxen tablets work to inhibit leukemia progression?

A: Ponatinib selectively inhibits the BCR-ABL tyrosine kinase enzyme, blocking signaling pathways essential for the growth and survival of malignant leukemia cells.

Q: What is the recommended dosage form and strength of Ponaxen for leukemia patients?

A: Ponaxen is provided as 15mg film-coated oral tablets, with dosages prescribed by healthcare professionals based on patient condition and treatment response.

Q: Are there special storage requirements for Ponatinib Tablets Ponaxen 15mg?

A: Yes, tablets should be stored between 20°C and 25°C, protected from moisture and light to maintain potency and stability.

Q: Is Ponatinib Tablets Ponaxen 15mg available without a prescription?

A: No, Ponatinib Tablets Ponaxen 15mg is a prescription-only medication and requires authorization by a qualified healthcare provider.

Q: What quality standards does Ponaxen adhere to during manufacturing?

A: Ponaxen is manufactured under stringent pharmaceutical quality standards, ensuring purity, safety, and consistent efficacy for effective leukemia treatment.

Question not answered? Ask sellers directly — typical response within 4 hours.